Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Effects of proton pump inhibitors on pediatric inflammatory esophagogastric polyps.
Choi KE, Kim MJ, Lee JH, Lee JS, Lee JH, Choe YH.
Digestion. 2012;85(3):179-84. Epub 2012 Jan 13.
Related citations
Gastric cancer development after Helicobacter pylori eradication therapy: a new form of gastric neoplasia.
Matsuo T, Ito M, Tatsugami M, Boda T, Takata S, Tanaka S, Chayama K.
Digestion. 2012;85(1):61-7. Epub 2012 Jan 5.
Helicobacter pylori eradication improves gastric atrophy and intestinal metaplasia in long-term observation.
Kodama M, Murakami K, Okimoto T, Abe T, Nakagawa Y, Mizukami K, Uchida M, Inoue K, Fujioka T.
Digestion. 2012;85(2):126-30. Epub 2012 Jan 19.
Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials.
Yang Z, Wu Q, Liu Z, Wu K, Fan D.
Digestion. 2011;84(4):315-20. Epub 2011 Nov 9.
Gastric wash-based molecular testing for antibiotic resistance in Helicobacter pylori.
Baba S, Oishi Y, Watanabe Y, Oikawa R, Morita R, Yoshida Y, Hiraishi T, Maehata T, Nagase Y, Fukuda Y, Nakazawa M, Ishigouoka S, Hattori N, Suzuki H, Toyota M, Niwa H, Suzuki M, Itoh F.
Digestion. 2011;84(4):299-305. Epub 2011 Nov 3.
Improvement of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms during proton pump inhibitor treatment: are G-protein β3 subunit genotype, Helicobacter pylori status, and environmental factors response modifiers?
Holtmann G, van Rensburg C, Schwan T, Sander P, Siffert W.
Digestion. 2011;84(4):289-98. Epub 2011 Oct 26.
Helicobacter pylori infection and the respiratory system: a systematic review of the literature.
Malfertheiner MV, Kandulski A, Schreiber J, Malfertheiner P.
Digestion. 2011;84(3):212-20. Epub 2011 Jul 12. Review.
Healing effects of rebamipide and omeprazole in Helicobacter pylori-positive gastric ulcer patients after eradication therapy: a randomized double-blind, multinational, multi-institutional comparative study.
Song KH, Lee YC, Fan DM, Ge ZZ, Ji F, Chen MH, Jung HC, Bo J, Lee SW, Kim JH.
Digestion. 2011;84(3):221-9. Epub 2011 Jul 8.
Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality.
Lau JY, Sung J, Hill C, Henderson C, Howden CW, Metz DC.
Digestion. 2011;84(2):102-13. Epub 2011 Apr 14. Review.
Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial.
Kawano S, Okada H, Kawahara Y, Hori K, Tanioka D, Tsuzuki T, Inoue M, Yagi S, Takenaka R, Yamamoto K.
Digestion. 2011;84(1):46-53. Epub 2011 Feb 8.
Effect of proton-pump inhibitor therapy on serum chromogranin a level.
Pregun I, Herszényi L, Juhász M, Miheller P, Hritz I, Patócs A, Rácz K, Tulassay Z.
Digestion. 2011;84(1):22-8. Epub 2011 Feb 8.
Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis.
Wang J, Xu L, Shi R, Huang X, Li SW, Huang Z, Zhang G.
Digestion. 2011;83(4):253-60. Epub 2011 Feb 1.
Gastric atrophy reversible or irreversible after Helicobacter pylori eradication - an open question.
Malfertheiner P.
Digestion. 2011;83(4):250-2. Epub 2011 Jan 28. No abstract available.
Usefulness of magnifying narrow-band imaging endoscopy in the Helicobacter pylori-related chronic gastritis.
Okubo M, Tahara T, Shibata T, Nakamura M, Kamiya Y, Yoshioka D, Maeda Y, Yonemura J, Ishizuka T, Arisawa T, Hirata I.
Digestion. 2011;83(3):161-6. Epub 2011 Jan 21. Review.
Relationship between Helicobacter pylori tyrosine-phosphorylated CagA-related markers and the development of diffuse-type gastric cancers: a case-control study.
Wada Y, Ito M, Takata S, Tanaka S, Yoshihara M, Chayama K.
Digestion. 2010;82(1):10-7. Epub 2010 Feb 9.
Helicobacter pylori eradication prevents extension of intestinalization even in the high-risk group for gastric cancer.
Shiotani A, Nishi R, Uedo N, Iishi H, Tsutsui H, Ishii M, Imamura H, Kamada T, Hata J, Haruma K.
Digestion. 2010;81(4):223-30. Epub 2010 Jan 29.
Does pretreatment with lansoprazole influence Helicobacter pylori eradication rate and quality of life?
Inoue M, Okada H, Hori S, Kawahara Y, Kawano S, Takenaka R, Toyokawa T, Onishi Y, Shiratori Y, Yamamoto K.
Digestion. 2010;81(4):218-22. Epub 2010 Jan 20.
Celecoxib inhibits CD133-positive cell migration via reduction of CCR2 in Helicobacter pylori-infected Mongolian gerbils.
Futagami S, Hamamoto T, Shimpuku M, Nagoya H, Kawagoe T, Horie A, Shindo T, Gudis K, Sakamoto C.
Digestion. 2010;81(3):193-203. Epub 2010 Jan 19.
Sleep dysfunction in Japanese patients with gastroesophageal reflux disease: prevalence, risk factors, and efficacy of rabeprazole.
Fujiwara Y, Kohata Y, Kaji M, Nebiki H, Yamasaki T, Sasaki E, Hayakawa T, Machida H, Tanigawa T, Watanabe K, Watanabe T, Tominaga K, Arakawa T.
Digestion. 2010;81(3):135-41. Epub 2010 Jan 14.
Leptin promotes gastric ulcer healing via upregulation of vascular endothelial growth factor.
Tanigawa T, Watanabe T, Otani K, Nadatani Y, Machida H, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, Higuchi K, Arakawa T.
Digestion. 2010;81(2):86-95. Epub 2010 Jan 9.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on